| Micro and nanoscale technologies in oral drug delivery S Ahadian, JA Finbloom, M Mofidfar, SE Diltemiz, F Nasrollahi, E Davoodi, ... Advanced drug delivery reviews 157, 37-62, 2020 | 151 | 2020 |
| Amphiphilic gradient copolymers of 2‐methyl‐and 2‐phenyl‐2‐oxazoline: self‐organization in aqueous media and drug encapsulation Y Milonaki, E Kaditi, S Pispas, C Demetzos Journal of Polymer Science Part A: Polymer Chemistry 50 (6), 1226-1237, 2012 | 95 | 2012 |
| Imaging the porous structure in the core of degrading PLGA microparticles: the effect of molecular weight I Mylonaki, E Allémann, F Delie, O Jordan Journal of controlled release 286, 231-239, 2018 | 51 | 2018 |
| Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia I Mylonaki, F Strano, S Deglise, E Allémann, F Alonso, JM Corpataux, ... Journal of Controlled Release 232, 93-102, 2016 | 39 | 2016 |
| Atorvastatin-loaded hydrogel affects the smooth muscle cells of human veins C Dubuis, L May, F Alonso, L Luca, I Mylonaki, P Meda, F Delie, O Jordan, ... Journal of Pharmacology and Experimental Therapeutics 347 (3), 574-581, 2013 | 36 | 2013 |
| Perivascular medical devices and drug delivery systems: Making the right choices I Mylonaki, É Allémann, F Saucy, JA Haefliger, F Delie, O Jordan Biomaterials 128, 56-68, 2017 | 30 | 2017 |
| Evaluating intimal hyperplasia under clinical conditions I Mylonaki, E Allain, F Strano, E Allémann, JM Corpataux, P Meda, ... Interactive cardiovascular and thoracic surgery 27 (3), 427-436, 2018 | 16 | 2018 |
| Design and characterization of a perivascular PLGA coated PET mesh sustaining the release of atorvastatin for the prevention of intimal hyperplasia I Mylonaki, O Trosi, E Allémann, M Durand, O Jordan, F Delie International journal of pharmaceutics 537 (1-2), 40-47, 2018 | 9 | 2018 |
| Perivascular Administration of Atorvastatin Loaded in Microparticles and Hyaluronic Acid Gel to Prevent Intimal Hyperplasia in Venous Graft F Saucy, I Mylonaki, S Déglise, J Corpataux, C Dubuis, O Jordan, F Delie European Journal of Vascular and Endovascular Surgery 58 (6), e99-e100, 2019 | 1 | 2019 |
| Pharmaceutical formulation for use in the treatment and/or prevention of restenosis F Delie, O Jordan, L Ludmila, F Saucy, J Haefliger, I Mylonaki US Patent 10,363,227, 2019 | 1 | 2019 |
| Genetic Enhancement of Epicardial Paracrine Signalling for Cardiac Regeneration L Brito, I Mylonaki, CL Grigsby, H Seong, SG Higgins, N Smart, M Noseda, ... Circulation 144 (Suppl_1), A10747-A10747, 2021 | | 2021 |
| Stem cell viability and proliferation is maintained in vivo using an alginate patch designed for epicardial administration I Mylonaki, D Hachim, D Stuckey, M Colzani, L Gambarella, L Brito, ... Cytotherapy 22 (5), S205, 2020 | | 2020 |
| Epicardial cell transfection with cationic polymeric nanocomplexes L Brito, I Mylonaki, E Moroz, C Grigsby, N Smart, N Rosenthal, SE Harding, ... MARY ANN LIEBERT, INC, 2019 | | 2019 |
| Intracellular siRNA delivery using silicon nanoneedle arrays I Mylonaki, MS Amoli, L Brito, S Higgins, A Moore, Y Lin, H Seong, ... HUMAN GENE THERAPY 30 (2), A7-A7, 2019 | | 2019 |
| Epicardial cell transfection with cationic polymeric nanocomplexes L Brito, I Mylonaki, E Moroz, C Grigsby, N Smart, N Rosenthal, SE Harding, ... British Society for Gene and Cell Therapy Autumn Conference 30, 2019 | | 2019 |
| Sustained release systems for the perivascular administration of atorvastatin to prevent vein graft failure I Mylonaki J. Control. Release 232, 93-102, 2016 | | 2016 |
Olivier JordanSenior lecturer, University of GenevaVerified email at unige.ch
